Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leiomyoma 3Inflammation 2Frailty 2Small Cell Lung Carcinoma 1Radiodermatitis 1Prostatic Neoplasms 1Papillomavirus Infections 1Low-Grade Intraepithelial Neoplasia of Cervix 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Esophageal Neoplasms 1Deglutition Disorders 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Ultrasonography 3Tomography, X-Ray Computed 2Colonoscopy 2tremelimumab 1lenvatinib 1fluoromisonidazole 1epigallocatechin gallate 1durvalumab 1babao dan 1Weights and Measures 1Vitamin B 6 1Tomography 1Tidal Volume 1Surgical Procedures, Operative 1Standard of Care 1Shadowing Technique, Histology 1Radiotherapy 1Radiomics 1Probiotics 1Preoperative Exercise 1Positron-Emission Tomography 1Portasystemic Shunt, Transjugular Intrahepatic 1Population Groups 1Plasmapheresis 1Oxaliplatin 1Medical History Taking 1Mebendazole 1Liquid Biopsy 1Introns 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Cirrhosis × epigallocatechin gallate × Clear all
NCT06015022 2025-09-05

CATCH-B

University of Texas Southwestern Medical Center

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡